Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SRNE

Sorrento Therapeutics (SRNE)

Sorrento Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SRNE
DateTimeSourceHeadlineSymbolCompany
04/11/202308:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
28/10/202307:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
13/09/202311:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
29/08/202307:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
08/08/202306:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:SRNESorrento Therapeutics Inc
01/08/202320:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
13/07/202320:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRNESorrento Therapeutics Inc
22/06/202307:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRNESorrento Therapeutics Inc
21/06/202307:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
15/06/202323:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
05/06/202323:00GlobeNewswire Inc.Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the ANASDAQ:SRNESorrento Therapeutics Inc
19/05/202320:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
16/05/202305:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SRNESorrento Therapeutics Inc
16/05/202302:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
13/05/202307:29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRNESorrento Therapeutics Inc
09/05/202320:03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SRNESorrento Therapeutics Inc
03/05/202320:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
21/04/202307:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
21/04/202302:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
12/04/202322:51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SRNESorrento Therapeutics Inc
11/04/202307:23Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SRNESorrento Therapeutics Inc
11/04/202305:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
31/03/202321:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
21/03/202310:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRNESorrento Therapeutics Inc
20/03/202321:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
11/03/202303:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRNESorrento Therapeutics Inc
09/03/202306:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRNESorrento Therapeutics Inc
23/02/202301:25AllPennyStocks.comBankruptcy Court Approval Causes Premarket Buying PressureNASDAQ:SRNESorrento Therapeutics Inc
22/02/202309:57PR Newswire (US)Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 CaseNASDAQ:SRNESorrento Therapeutics Inc
22/02/202308:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRNESorrento Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SRNE